Abstract
In the Systolic Blood Pressure Intervention Trial (SPRINT), intensive (systolic blood pressure [SBP] goal 1,2 While Williamson et al1 have previously shown that intensive treatment reduced the risk of MCI or probable dementia overall on average, the study did not address treatment effect heterogeneity and which populations derive the greatest absolute benefit for prioritization. As we have previously seen, the magnitude of absolute benefit from intensive treatment for CVD outcomes was greatest for those at highest baseline CVD risk, and this population should initially be targeted.3 As such, cognitive benefit from intensive vs standard SBP treatment may vary among patients.

This publication has 39 references indexed in Scilit: